{"organizations": [], "uuid": "d5492740a6fb126468bb4bff1e460a70ae0a5013", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180117.html", "section_title": "Archive News &amp; Video for Wednesday, 17 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-isofol-medical-successful-regulato/brief-isofol-medical-successful-regulatory-meeting-with-fda-idUSFWN1PB1DI", "country": "US", "domain_rank": 408, "title": "BRIEF-Isofol Medical: Successful Regulatory Meeting With FDA", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.324, "site_type": "news", "published": "2018-01-17T15:19:00.000+02:00", "replies_count": 0, "uuid": "d5492740a6fb126468bb4bff1e460a70ae0a5013"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-isofol-medical-successful-regulato/brief-isofol-medical-successful-regulatory-meeting-with-fda-idUSFWN1PB1DI", "ord_in_thread": 0, "title": "BRIEF-Isofol Medical: Successful Regulatory Meeting With FDA", "locations": [], "entities": {"persons": [], "locations": [{"name": "us", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 17 (Reuters) - ISOFOL MEDICAL AB:\n* SUCCESSFUL END-OF-PHASE 2 MEETING WITH FDA AND PHASE 3 PROGRAM FOR MODUFOLIN® AGREED\n* ‍HAS HAD SUCCESSFUL REGULATORY MEETING WITH US FDA, IMPORTANT MILESTONE IN REGULATORY PROCESS​\n* ‍PHASE III STUDY, ISO-CC-007, IS EXPECTED TO BE COMPLETED BY 2020/2021​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-17T15:19:00.000+02:00", "crawled": "2018-01-18T16:24:52.000+02:00", "highlightTitle": ""}